EFFECTS OF PLACEBO-CONTROLLED WITHDRAWAL AFTER LONG-TERM OPEN LABEL TREATMENT WITH OROS MPH IN ADULTS WITH ADHD

被引：0
|
作者：
Kooij, S. [1 ]
Nyrerod, H. J. [2 ]
Casas, M. [3 ]
Dejonckheere, J. [4 ]
Waechter, S. [5 ]
van Oene, J. [6 ]
Schaeuble, B. [7 ]
Buitelaar, J. [8 ]
机构：
[1] Psycho Med Ctr, Parnassia, Den Haag, Netherlands
[2] Sykehuset Buskerrud HF, Drammen Psykiatriske Senter, Drammen, Norway
[3] C Emancipacio, Psychiat, Barcelona, Spain
[4] SGS Life Sci Serv, Antwerp, Belgium
[5] Janssen Cilag Switzerland, EMEA Med Affairs, Baar, Switzerland
[6] Janssen Pharmaceut, EMEA Med Affairs, Tilburg, Netherlands
[7] Janssen Cilag GmbH, EMEA Med Affairs, Neuss, Germany
[8] UMC St Radbout, Psychiat, Nijmegen, Netherlands
来源：
EUROPEAN PSYCHIATRY | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long-term treatment outcomes in adults with ADHD treated with OROS MPH
    Schaeuble, B.
    Hofecker, M.
    Buitelaar, J. K.
    Konofal, E.
    Kooij, S.
    Dejonckheere, J.
    Waechter, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 470 - 470
  • [2] ADHD treatment with once-daily OROS® MPH:: A long-term, open-label study of safety and tolerability
    Wolraich, ML
    PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [3] Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD
    Buitelaar, Jan K.
    Trott, Goetz-Erik
    Hofecker, Maria
    Waechter, Sandra
    Berwaerts, Joris
    Dejonkheere, Joachim
    Schaeuble, Barbara
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (01): : 1 - 13
  • [4] The incidence of personality disorder in adults with ADHD, and the effects on response to treatment with OROS methylphenidate (OROS MPH)
    Casciol, Carissa
    Sassoon, Rachel E.
    Carroll-Sharpe, Abigail
    Essick, Gregory K.
    Baranek, Grace T.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 245S - 245S
  • [5] Assessing Personality Disorder in Adults With ADHD, and its Effects on Response to Treatment with OROS® Methylphenidate (OROS® MPH)
    Robison, Reid
    Reimherr, Frederick W.
    Marchant, Barrie K.
    Gale, Phillip
    Williams, Erika D.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonam
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 632 - 632
  • [6] A PLACEBO-CONTROLLED INVESTIGATION OF DUODENAL-ULCER RECURRENCE AFTER WITHDRAWAL OF LONG-TERM TREATMENT WITH RANITIDINE
    PENSTON, JG
    DIXON, JS
    BOYD, EJS
    WORMSLEY, KG
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1993, 7 (03) : 259 - 265
  • [7] ADHD treatment with once-daily OROS methylphenidate: Final results from a long-term open-label study
    Wilens, T
    McBurnett, K
    Stein, M
    Lerner, M
    Spencer, T
    Wolraich, M
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (10): : 1015 - 1023
  • [8] Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies
    Goodman, David W.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 121 - 130
  • [9] OROS® methylphenidate treatment for ADHD:: Long-term effect on growth
    Biederman, J
    Stephen, F
    Spencer, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S274 - S274
  • [10] Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: a randomized, placebo-controlled discontinuation study
    Rosenau, Paul T.
    Openneer, Thaira J. C.
    Matthijssen, Anne-Flore M.
    Van de Loo-Neus, Gigi H. H.
    Buitelaar, Jan K.
    van den Hoofdakker, Barbara J.
    Hoekstra, Pieter J.
    Dietrich, Andrea
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2021, 62 (12) : 1444 - 1452
12345